Claims
- 1. A method for preparing inhibitor compounds for in vitro testing of in vivo drug-drug interactions in mammals, wherein the method comprises the automated steps of:a) retrieving frozen microsomes of a mammal species from a freezer storage unit; b) thawing the retrieved frozen microsomes; c) mechanically introducing a pre-determined quantity of (i) the thawed microsomes, (ii) a cofactor, and (iii) a buffer into individual wells of a multiwell reaction plate and pre-incubating the reaction plate with contained microsomes to an in vivo temperature for said mammal for a pre-determined period of time; d) mechanically combining the thawed microsomes in each of the wells of the reaction plate with a pre-determined quantity of a combination of one of said inhibitor compounds and a preselected probe substrate specific for cytochrome P450s (CYP); e) incubating the reaction plate with contained microsomes, CYP-specific probe substrate and inhibitor compounds to said in vivo temperature for a pre-determined period of time, to effect reaction in the individual wells, with resultant respective reaction products; f) stopping any reactions which occur, at the end of the pre-determined period of time, purifying the reaction products and using the reaction products in an analysis test for determining the extent of any drug-drug interactions relative to the respective inhibitor compounds and respective CYP-specific probe substrate; wherein steps c-f are repeated for a pre-determined number of times as individual test runs, with pre-thawed microsome samples, wherein, simultaneously with the steps of c-f of one run, additional microsomes are removed from the freezer unit, thawed, and held at a holding site, for immediate use in steps c-f of a subsequent test run, wherein timing of when the frozen microsomes are initially removed for thawing during steps c-f is such that removal is at the same point in time during said steps of each of the individual test runs and wherein duration of thawing and any pre-incubation is the same for all of the runs and incubation periods are pre-calculated and adapted to be of the same duration for each paired set of plates during a test run.
- 2. The method of claim 1, wherein the mechanical introducing is effected with multiple cannula elements automatically operable with computer controlled aspiration and dispensing of fluid solutions.
- 3. A method for preparing inhibitor compounds for in vitro testing of in vivo drug-drug interactions in mammals, where the method comprises the automated steps of:a) retrieving frozen microsomes from a freezer storage unit with an automated mechanical transport mechanism; b) thawing the frozen microsomes; c) automatically mechanically introducing measured amounts of the microsomes and buffer, into a receptacle trough, with cofactor; d) automatically mechanically introducing equal amounts of the combination of thawed microsomes, buffer and cofactor, into individual wells of a multiwell reaction plate; e) thereafter automatically mechanically transporting the multiwell reaction plate to a heating device for pre-incubation heating of the combination of thawed microsomes, buffer, and cofactor for a pre-determined period of time; f) automatically mechanically introducing a mixture of a preselected CYP-specific probe substrate and an inhibitor compound solution to the combination of microsomes, buffer, and cofactor in the incubated multiwell reaction plate and mixing; g) thereafter incubating the reaction plate to an in vivo temperature for said mammal for a pre-determined period of time; h) stopping any reaction which may have occurred after said pre-determined period of time; i) mechanically introducing pre-determined amounts of the reaction mixture into individual wells of a multiwell filtration plate, and vacuum filtering any reaction product therein; j) using the reaction product in an analysis test to determine the extent, if any, of drug-drug interactions of said compound; wherein steps c-j are repeated for a pre-determined number of times as individual test runs, with pre-thawed microsome samples; wherein, simultaneously with the steps of c-i of one run, additional microsomes are removed from the freezer unit, thawed, and held at a holding site, for immediate use in steps c-j of a subsequent test run; and wherein timing of when the frozen microsomes are initially removed for thawing during steps c-j is such that removal is at the same point in time during said steps of each of the individual test runs and wherein, duration of thawing is the same for all of the runs and all pre-incubation and incubation periods of all individual test runs are pre-calculated and adapted to be of substantially the same duration.
Parent Case Info
This application claims the benefit o U.S. Provisional Application No. 60/208,213, filed May 31, 2000.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
6124282 |
Sellers et al. |
Sep 2000 |
A |
Non-Patent Literature Citations (1)
Entry |
Chauret et al. (Anal. Biochem. (Dec. 15, 1999) 276 (2) 215-26). |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/208213 |
May 2000 |
US |